Skip to content

Home
About Us
- Board of Directors
- Management Team
Technology
News/Resources
Investor Centre
Contacts

ASX Announcements 2021

16 Dec 2021
Update on Biotron’s HIV-1 and COVID-19 Programs
25 Nov 2021
Biotron Drug Effective Against COVID-19 in Animals
23 Nov 2021
Results of Annual General Meeting
23 Nov 2021
Presentation to Annual General Meeting
1 Nov 2021
Commencement of Two Pivotal BIT225 Clinical Trials
28 Oct 2021
Report on Activities for the Quarter Ended 30 September 2021
28 Oct 2021
Quarterly Report 30 September 2021
20 Oct 2021
Annual Report and Notice of AGM
27 Aug 2021
Year End Accounts and Preliminary Final Report
27 Aug 2021
Appendix 4G and Corporate Governance Statement 2021
30 Jul 2021
Report on Activities for the Quarter Ended 30 June 2021
30 Jul 2021
Quarterly Report 30 June 2021
8 Jul 2021
Shareholder Update
2 Jul 2021
Notification of Cessation of Securities
29 Apr 2021
R&D Tax Incentive
29 Apr 2021
Report on Activities for the Quarter ended 31 March 2021
29 Apr 2021
Quarterly Report 31 March 2021
11 Mar 2021
Lead Series for SARS-CoV-2 Program
24 Feb 2021
Half-year Report 31 December 2020
1 Feb 2021
Report on Activities for the Quarter ended 31 December 2020
1 Feb 2021
Quarterly Report 31 December 2020

<<
2024

2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
>>

Investor Centre

Investor Centre

© Biotron Limited 2016 ABN 60 086 399 144 Site updated 6 September 2024 Legal Notices and Privacy